Formulation and in-vitro Evaluation of Baclofen loaded Transferosomal Gel
Abstract
Baclofen is a class of medications called skeletal muscle relaxant. It is a class III drug having low solubility and high permeability used in treating multiple sclerosis symptoms such as spasticity, stiffness, and pain. The current study involves the development and in-vitro evaluation of a Baclofen-loaded transfersomal gel to reduce dosage frequency. Drug and excipient interactions were not detected in the FTIR spectra. Hand shaking modified thin film hydration method was used to developed transfersome formulations, which then consolidated at 0.5% carbopol gel. Optimized BF7 formulation provides higher Entapment efficiency and maximum drug delivery. The prepared formulation had been examined for FTIR, Organoleptic evaluation, Viscosity, Spread-ability, Entrapment Efficacy, Drug content, SEM analysis, Particle size, Zeta potential, Stability testing, and other parameters. The optimised formulation BF7 confirmed Entapment Efficiency ranging from 80.04 to 87.42%, Drug content ranging from 90.26 -95.37%, Vesicle Size of 167.8nm & In-vitro diffusion of 97.48%. The drug release data from the chosen gel demonstrated a good fit with the Higuchis and Zero order release kinetics.
Keywords: Transferosomes, vesicular drug delivery system, Thin film hydration method
Keywords:
Transferosomes, vesicular drug delivery system, Thin film hydration methodDOI
https://doi.org/10.22270/jddt.v13i12.6015References
Barry B: Transdermal Drug Delivery, in Pharmaceutics. The Science of Dosage Form Design, ed. Aulton E. M., Churchill Livingstone, 2002.P.499-5283.
Honeywell - Nguyen P. L., Bouwstra J. A. “Vesicles as a Tool for Transdermal and Dermal Delivery”. Drug discovery Today: Technologies., 2. 2005. P.67-74.
Bain KR., Hadgkraft AJ, James WJ, and Water KA. “Prediction of percutaneous penetration”. STS Publishing, Cardiff. 3b.1993. P. 226-234.
Cevc G, Blume G, Sehatzlein A, Gebauer D and Paul A. “The skin- a pathway for systemic treatment with patches and lipid-based agent carriers”. Advance Drug Delivery Reviews., 18. 1996.P. 349- 378.
Chaurasiya P. Ganju E., Upmanyu N. Ray S.K. Jain P. “Transfersomes: A novel technique for transdermal drug delivery” Journal of Drug Delivey and Therapeutics, 2019; 9, 279–285. DOI: https://doi.org/10.22270/jddt.v9i1.2198.
Sachan R. Parashar T. Soniya, S.V.Singh, G.Tyagi, S. Patel, C.Gupta, A. “Drug carrier transfersomes: A novel tool for transdermal drug delivery system” International Journal of Research Development Pharmaceutical Life Scences, 2013;2:309-316. DOI: https://www.researchgate.net/publication/305387042_Drug_carrier_transfersomes_a_novel_tool_for_transdermal_drug_delivery_system.
Modi, C. Bharadia, P. “Transfersomes: New dominants for transdermal drug delivery” American journal of PharmTech Research, 2012; 2:71-91. DOI: https://www.researchgate.net/publication/267856285_Transfersomes_New_Dominants_for_Transdermal_Drug_Delivery.
Gupta R, Kumar A. “Transfersomes: The Ultra-Deformable Carrier System for Non-Invasive Delivery of Drug” Current Drug Delivery,2021;18(4):408-420. DOI: https://doi.org/10.2174/1567201817666200804105416 .
Raveendhra K, Kothamasu S, Formulation and evaluation of controlled release topical gel of . International Journal of Nanomedicine, 2019;14:1551–1562. DOI: http://www.thepharmajournal.com.
Jain NK. Advances in Controlled and Novel Drug Delivery. First edition. New Delhi: CBS Publishers and Distributers; 2001. P. 426-451.
Yussef, Fayez, Sakran, “Formulation and Evaluation of Baclofen Polymeric Nanoparticles for Transdermal Delivery In -vitro and Ex-vivo Optimization” Journal of Advanced Pharmaceutical Research, 2021;5(2):248-276. DOI:https://dx.doi.org/10.21608/aprh.2021.68835.1125.
Ali SS, Gudipati M, Nadendla R, Development and characterization of miconazole nitrate transfersomal gel. International Journal of Research in Pharmaceutical Sciences and Technology, 2020; 1(4):109-116. DOI: https://doi.org/10.33974/ijrpst.v1i4.200.
Kumar A “Transferosome: A recent approach for transdermal drug delivery” Journal of Drug Delivery and Therapeutics, 2018;8(5-s):100-4. DOI: https://doi.org/10.22270/jddt.v8i5-s.1981.
Taymouri S, Hajhashemi V, Tabbakhian M, Torkashvand “Preparation and Evaluation of Imatinib Loaded Transfersomal gel for the Treatment of Rheumatoid Arthritis” Iranian Journal Pharmaceutical Research, 2021;20(4):33-46. DOI: https://doi.org/10.22037%2Fijpr.2021.115481.15394
Malakar J, Sen SO, Nayak AK, Sen K. “Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery” Saudi Pharmaceutical journal,2012;20:355–63. https://doi.org/10.1016%2Fj.jsps.2012.02.001.
Omar MM, Hasan OA, El Sisi AM. “Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation” International Journal of Nanomedicine, 2019;14:1551-1562DOI: https://doi.org/10.2147/IJN.S201356
Published
Abstract Display: 814 
PDF Downloads: 705 PDF Downloads: 208 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.